Clinical Trial Update: Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of dalfampridine with locomotor training for chronic motor incomplete spinal cord injury has completed. The snippet rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

Sponsor: Kessler Foundation | Conditions: Spinal Cord Injury | Phase 2 | Status: COMPLETED